[Co-trimoxazol (Eusaprim) and deoxycycline (Vibramycin) compared to placebo in the prevention of recurrent respiratory tract infections in CARA-patients].
D001773:Blood Cells; D001982:Bronchial Diseases / Q000517:prevention & control; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D010919:Placebos; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use*
D010919:Placebos; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D004318:Doxycycline
Co-trimoxazol (Eusaprim) en doxycycline (Vibramycine) vergeleken met placebo bij de preventie van recidiverende luchtweginfecties bij CARA-patiënten.